U.S., May 10 -- ClinicalTrials.gov registry received information related to the study (NCT06963775) titled 'Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials' on March 07.
Brief Summary: Patients evaluated at Penn Presbyterian Medical Center for traumatic brain injury (TBI), who sign the informed consent, will undergo assessment of electrophysiologic potentials evoked by transcranial magnetic stimulation (TMS), using the Delphi-MD device (QuantalX Neuroscience Ltd., Saba Israel).
Study Start Date: May 01
Study Type: OBSERVATIONAL
Condition:
Traumatic Brain Injury
Intervention:
DEVICE: Delphi-MD device (QuantalX Neuroscience Ltd., Saba Israel)
Delphi-MD utilizes the use of transcranial magn...